Ryvu Therapeutics SA Capital Reinvestment Ratio
Ryvu Therapeutics SA capital reinvestment ratio. Ryvu Therapeutics SA (RVU) has a Capital Reinvestment Ratio of 0.07x as of December 2022, meaning it reinvests 0% of its operating cash flow (zł59.92 Million) in capital expenditures (zł4.22 Million). Check RVU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ryvu Therapeutics SA (2017–2022)
Capital reinvestment ratio of Ryvu Therapeutics SA from 2017 to 2022. This chart tracks Ryvu Therapeutics SA's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset growth rate of Ryvu Therapeutics SA to track the company's year-over-year net asset growth rate.
Ryvu Therapeutics SA Capital Reinvestment Ratio by Year (2017–2022)
Ryvu Therapeutics SA capital reinvestment ratio by year from 2017 to 2022. For the full cash flow conversion analysis, see RVU cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.44x | zł21.32 Million | zł9.29 Million | ▼ -77.8% |
| 2017 | 1.96x | zł10.98 Million | zł21.56 Million | — |